查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576860

Granisetron市場：按產品類型、應用、最終用戶、分銷管道分類 - 全球預測 2025-2030

Granisetron Market by Product Type, Application, End Users, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Granisetron市場價值為70.1億美元，預計到2024年將達到74.3億美元，複合年成長率為6.58%，預計到2030年將達到109.6億美元。

Granisetron是一種選擇性5-HT3受體拮抗劑，主要用於預防化療、放射線治療和術後環境引起的噁心和嘔吐。對Granisetron的需求源於其能夠有效解決癌症治療中常見的和使人衰弱的副作用，從而提高患者的生活品質和治療依從性。Granisetron的應用範圍廣泛，包括醫院、腫瘤診所和術後恢復中心，使其成為綜合癌症治療方法的重要組成部分。隨著經皮貼片和緩釋性注射等新配方的開發，以提高便利性和患者依從性，最終用途的範圍正在擴大。

主要市場統計
基準年[2023] 70.1億美元
預測年份 [2024] 74.3億美元
預測年份 [2030] 109.6億美元
複合年成長率（%） 6.58%

Granisetron市場受到癌症發病率上升、化療和放射線治療日益普及以及藥物輸送系統進步等因素的影響。新興國家癌症患者人數的成長帶來了市場機會，這些國家的醫療基礎設施和癌症治療的機會正在擴大。此外，專注於個人化醫療和聯合治療的技術創新有望擴大Granisetron的治療範圍，並為醫療保健行業的公司提供競爭優勢。

然而，它們面臨著許多挑戰，包括高昂的市場開拓成本、導致學名藥競爭的專利到期以及減緩市場進入的嚴格監管流程。由於副作用和相互作用，也存在潛在的局限性，這需要仔細的患者管理和配方改進。

為了推動業務成長，公司應專注於生物相似藥開發、創新藥物輸送方法以及針對特定患者需求和當地醫療保健需求的改進配方等研究領域。此外，投資於病患教育舉措和數位健康平台可以提高市場滲透率和品牌忠誠度。在技​​術進步和對改進止吐治療的持續需求的推動下，市場動態本質上仍然是動態和競爭的。雖然北美和歐洲市場以先進的醫療設施為主，但由於醫療成本和癌症發病率的上升，亞太地區提供了巨大的成長潛力。

市場動態：揭示快速發展的Granisetron市場的關鍵市場洞察

供需的動態交互作用正在改變Granisetron市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 新興市場醫療保健基礎設施的開拓加速了市場擴張。
    • 不斷成長的醫療保健支出推動了Granisetron等先進止吐療法的採用
    • 製藥公司之間的策略聯盟加速Granisetron創新和市場滲透
    • 有利的止吐藥報銷政策推動Granisetron的使用
  • 市場限制因素
    • 避免專利到期及其對Granisetron市場動態的影響
  • 市場機會
    • 使用Granisetron創新癌症治療並改善癌症患者的護理
    • 擴大Granisetron在胃腸道疾病和噁心治療中的仿單標示外使用
    • 將Granisetron入個人化醫療改善患者預後
  • 市場挑戰
    • 影響Granisetron穩定供應的供應鏈漏洞

波特五力：駕馭Granisetron市場的策略工具

波特的五力架構是了解Granisetron市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解Granisetron市場的外部影響

外部宏觀環境因素在塑造Granisetron市場的業績動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解Granisetron市場的競爭狀況

對Granisetron市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣Granisetron市場供應商績效評估

FPNV定位矩陣是評估Granisetron市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了Granisetron市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，Granisetron市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 發展中地區醫療基礎設施的擴張加速了Granisetron市場的擴張
      • 不斷上漲的醫療費用正在推動Granisetron等先進止吐療法的推出。
      • 製藥公司之間的策略聯盟推動Granisetron的創新和市場滲透
      • 止吐藥優惠報銷政策鼓勵Granisetron廣泛使用
    • 抑制因素
      • 克服專利到期及其對Granisetron市場趨勢的影響
    • 機會
      • 利用Granisetron創新腫瘤治療並改善癌症患者照護
      • 擴大Granisetron在胃腸道疾病和噁心治療中的仿單標示外使用
      • 將Granisetron入個人化醫療方法，以改善患者的治療效果
    • 任務
      • 供應鏈漏洞影響Granisetron的持續可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章Granisetron市場：依產品類型

  • 注射液
  • 口服液

第7章Granisetron市場：依應用分類

  • 化療引起的噁心和嘔吐
  • 術後噁心、嘔吐
  • 放射治療引起的噁心和嘔吐

第8章Granisetron市場：依最終用戶分類

  • 診所
    • 普通科診所
    • 腫瘤門診
  • 居家護理
  • 醫院
    • 私立醫院
    • 公立醫院

第9章Granisetron市場：按通路

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章Granisetron美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區Granisetron市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲Granisetron市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-535C62918923

The Granisetron Market was valued at USD 7.01 billion in 2023, expected to reach USD 7.43 billion in 2024, and is projected to grow at a CAGR of 6.58%, to USD 10.96 billion by 2030.

Granisetron is a selective 5-HT3 receptor antagonist primarily used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and post-operative environments. The necessity for Granisetron stems from its effectiveness in addressing a prevalent and debilitating side effect of cancer treatment, thereby improving patient quality of life and treatment compliance. Its applications span hospitals, oncology clinics, and post-surgical recovery centers, forming a crucial component of comprehensive cancer care regimens. The end-use scope broadens as newer formulations such as transdermal patches and extended-release injections are developed, offering both convenience and improved patient adherence.

KEY MARKET STATISTICS
Base Year [2023] USD 7.01 billion
Estimated Year [2024] USD 7.43 billion
Forecast Year [2030] USD 10.96 billion
CAGR (%) 6.58%

The market for Granisetron is influenced by factors such as the rising prevalence of cancer, increasing adoption of chemotherapy and radiotherapy, and ongoing advancements in drug delivery systems. Market opportunities arise from the growth in cancer patient populations in emerging economies, where healthcare infrastructure and access to cancer care are expanding. Additionally, innovations focusing on personalized medicine and combination therapies are poised to expand the therapeutic scope of Granisetron, offering a competitive edge for businesses in the healthcare sector.

However, the market faces challenges, including the high cost of drug development, patent expirations leading to generic competition, and stringent regulatory processes that can delay market entry. Potential limitations also arise from adverse drug reactions and interactions, necessitating careful patient management and drug formulation enhancements.

To drive business growth, organizations should focus on research areas such as the development of biosimilars, innovative drug delivery methods, and enhanced formulations tailored to specific patient needs and regional healthcare demands. Additionally, investing in patient education initiatives and digital health platforms can enhance market penetration and brand loyalty. The nature of the Granisetron market remains dynamic and competitive, driven by technological advancements and a constant demand for improved antiemetic therapies. North American and European markets hold the lion's share due to advanced healthcare facilities, while Asia-Pacific offers substantial growth potential given its increasing healthcare expenditure and cancer incidence rates.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Granisetron Market

The Granisetron Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
    • Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
    • Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
    • Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
  • Market Restraints
    • Navigating patent expirations and their impact on Granisetron market dynamics
  • Market Opportunities
    • Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
    • Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
    • Integrating granisetron into personalized medicine approaches for better patient outcomes
  • Market Challenges
    • Supply chain vulnerabilities impacting the consistent availability of Granisetron

Porter's Five Forces: A Strategic Tool for Navigating the Granisetron Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Granisetron Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Granisetron Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Granisetron Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Granisetron Market

A detailed market share analysis in the Granisetron Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Granisetron Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Granisetron Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Granisetron Market

A strategic analysis of the Granisetron Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Granisetron Market, highlighting leading vendors and their innovative profiles. These include Akorn, Allergan, Amgen, Apotex, Aurobindo Pharma, Baxter International, Cipla, Dr. Reddy's Laboratories, Endo International, Fresenius Kabi, Glenmark Pharmaceuticals, Hoffmann-La Roche, Lupin Pharmaceuticals, Mylan, Natco Pharma, Pfizer, Sandoz, Sun Pharmaceutical, Teva Pharmaceuticals, and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Granisetron Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Injectable Solution and Oral Solution.
  • Based on Application, market is studied across Chemotherapy-Induced Nausea And Vomiting, Postoperative Nausea And Vomiting, and Radiotherapy-Induced Nausea And Vomiting.
  • Based on End Users, market is studied across Clinics, Homecare, and Hospitals. The Clinics is further studied across General Clinics and Oncology Clinics. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
      • 5.1.1.2. Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
      • 5.1.1.3. Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
      • 5.1.1.4. Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
    • 5.1.2. Restraints
      • 5.1.2.1. Navigating patent expirations and their impact on Granisetron market dynamics
    • 5.1.3. Opportunities
      • 5.1.3.1. Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
      • 5.1.3.2. Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
      • 5.1.3.3. Integrating granisetron into personalized medicine approaches for better patient outcomes
    • 5.1.4. Challenges
      • 5.1.4.1. Supply chain vulnerabilities impacting the consistent availability of Granisetron
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Granisetron Market, by Product Type

  • 6.1. Introduction
  • 6.2. Injectable Solution
  • 6.3. Oral Solution

7. Granisetron Market, by Application

  • 7.1. Introduction
  • 7.2. Chemotherapy-Induced Nausea And Vomiting
  • 7.3. Postoperative Nausea And Vomiting
  • 7.4. Radiotherapy-Induced Nausea And Vomiting

8. Granisetron Market, by End Users

  • 8.1. Introduction
  • 8.2. Clinics
    • 8.2.1. General Clinics
    • 8.2.2. Oncology Clinics
  • 8.3. Homecare
  • 8.4. Hospitals
    • 8.4.1. Private Hospitals
    • 8.4.2. Public Hospitals

9. Granisetron Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Granisetron Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Granisetron Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Granisetron Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akorn
  • 2. Allergan
  • 3. Amgen
  • 4. Apotex
  • 5. Aurobindo Pharma
  • 6. Baxter International
  • 7. Cipla
  • 8. Dr. Reddy's Laboratories
  • 9. Endo International
  • 10. Fresenius Kabi
  • 11. Glenmark Pharmaceuticals
  • 12. Hoffmann-La Roche
  • 13. Lupin Pharmaceuticals
  • 14. Mylan
  • 15. Natco Pharma
  • 16. Pfizer
  • 17. Sandoz
  • 18. Sun Pharmaceutical
  • 19. Teva Pharmaceuticals
  • 20. Wockhardt

LIST OF FIGURES

  • FIGURE 1. GRANISETRON MARKET RESEARCH PROCESS
  • FIGURE 2. GRANISETRON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GRANISETRON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GRANISETRON MARKET DYNAMICS
  • TABLE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GRANISETRON MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GRANISETRON MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GRANISETRON MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GRANISETRON MARKET SIZE, BY RADIOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GRANISETRON MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GRANISETRON MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GRANISETRON MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GRANISETRON MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GRANISETRON MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GRANISETRON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GRANISETRON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023